StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the stock.
China Pharma Stock Up 7.3 %
China Pharma stock opened at $0.27 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19. China Pharma has a 52-week low of $0.17 and a 52-week high of $1.21. The company’s 50 day moving average is $0.21 and its two-hundred day moving average is $0.27.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- How Investors Can Find the Best Cheap Dividend Stocks
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- The Significance of Brokerage Rankings in Stock Selection
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- Consumer Staples Stocks, Explained
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
